THE Australian Self-Medication
Industry has downplayed the
relevance to Australian consumers
of Mon night’s ABC Four Corners
program about complementary
medicines (PD yesterday), with
ASMI ceo Deon Schoombie saying
“there is a vast difference between
the way the US and Australia
regulate these medicines”.
He said the TGA requires CMs
to be manufactured to medicinal
standards, with the agency
conducting a safety assessment on
ingredients in listed complementary
medicines.
“Companies marketing
complementary medicines can
only make limited claims regarding
their effectiveness and are required
to hold evidence supporting
these claims,” with the TGA also
maintaining a rigorous system
for recording, monitoring and
responding to adverse events for all
medicines, including CMs.The above article was sent to subscribers in Pharmacy Daily's issue from 18 May 16 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 18 May 16
MONTU Group, its subsidiary Alternaleaf Pty Ltd, and their common director Christopher Strauch are facing legal action by the Therapeutic Goods Administration (TGA) in the Federal Court of Australia for alleged unlawful advertising on the effectiveness of their medicinal cannabis products.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.